{"transactions":[{"id":696748,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2026-08-04T20:10:57.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":0.63,"exercise_date":"2027-07-31","expiration_date":"2036-07-31","underlying":"Voting Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-26-085191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781292/000121390026085191/ownership.xml","form_type":"4"}},{"id":703025,"issuer":{"id":5494,"kind":"organization","name":"Scribe Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Performance-based Stock Option (Right to Buy)","published_at":"2026-07-28T01:42:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":109426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options are eligible to vest upon the achievement of certain market-based performance criteria during a performance period beginning on July 23, 2026 and ending on July 23, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":109426,"derivative":{"exercise_price":15,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":109426},"source":{"system":"sec-edgar","filing":"0001781292-26-000007","document":"form4-07282026_010709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/form4-07282026_010709.xml","form_type":"4"}},{"id":703024,"issuer":{"id":5494,"kind":"organization","name":"Scribe Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-28T01:42:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":109426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest as to 1/48 of the total shares monthly over four years, with the first tranche scheduled to vest on August 23, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":109426,"derivative":{"exercise_price":15,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":109426},"source":{"system":"sec-edgar","filing":"0001781292-26-000007","document":"form4-07282026_010709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/form4-07282026_010709.xml","form_type":"4"}},{"id":703023,"issuer":{"id":5494,"kind":"organization","name":"Scribe Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-28T01:42:12.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":9547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transaction is reported herein pursuant to Rule 16a-2(a)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":9547,"derivative":{"exercise_price":19.13,"expiration_date":"2036-03-12","underlying":"Common Stock","underlying_shares":9547},"source":{"system":"sec-edgar","filing":"0001781292-26-000007","document":"form4-07282026_010709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/form4-07282026_010709.xml","form_type":"4"}},{"id":703022,"issuer":{"id":5494,"kind":"organization","name":"Scribe Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-07-28T01:42:12.000Z","date":"2026-07-23","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":15,"value":45000.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001781292-26-000007","document":"form4-07282026_010709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/form4-07282026_010709.xml","form_type":"4"}},{"id":780529,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-13T20:12:06.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":0.95,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001781292-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000178129226000003/ownership.xml","form_type":"4"}},{"id":1032764,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (right to buy)","published_at":"2025-09-24T20:01:38.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant."}],"balance_after":20000,"derivative":{"exercise_price":2.92,"exercise_date":"2026-03-22","expiration_date":"2030-03-22","underlying":"Voting Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-25-091104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781292/000121390025091104/ownership.xml","form_type":"4"}},{"id":1032763,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Stock","published_at":"2025-09-24T20:01:38.000Z","date":"2025-09-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.43,"value":48600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001213900-25-091104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781292/000121390025091104/ownership.xml","form_type":"4"}},{"id":1091761,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-03T20:20:10.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":6.77,"exercise_date":"2026-07-03","expiration_date":"2035-07-03","underlying":"Voting Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-25-061492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781292/000121390025061492/ownership.xml","form_type":"4"}},{"id":1160842,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-02T21:22:24.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":3.34,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-062942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000095017025062942/ownership.xml","form_type":"4"}},{"id":1472708,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T10:07:48.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on June 18, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":15000,"derivative":{"exercise_price":23.19,"expiration_date":"2034-06-18","underlying":"Voting Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-24-053989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781292/000121390024053989/ownership.xml","form_type":"4"}},{"id":1503375,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T23:19:41.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":24000,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000950170-24-064225","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000095017024064225/ownership.xml","form_type":"4"}},{"id":1884221,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T20:30:42.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":12000,"derivative":{"exercise_price":2.52,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123031016/doc4.xml","form_type":"4"}},{"id":1911196,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-04-28T20:53:12.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-026065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123026065/doc4.xml","form_type":"4"}},{"id":1911195,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-04-28T20:53:12.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-026065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123026065/doc4.xml","form_type":"4"}},{"id":2288639,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-28T23:50:16.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-026091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919122026091/doc4.xml","form_type":"4"}},{"id":2735622,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-30T00:11:17.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":4.21,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-21-029123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919121029123/doc4.xml","form_type":"4"}},{"id":3156060,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T21:08:21.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":3.65,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-20-027984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919120027984/doc4.xml","form_type":"4"}},{"id":3470547,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":26537,"kind":"person","name":"Lucas Svetlana","position":1,"cik":"0001781292","reported_name":"Lucas Svetlana","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-02T21:16:21.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":2285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019."}],"balance_after":2285,"derivative":{"exercise_price":5.1296,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":2285},"source":{"system":"sec-edgar","filing":"0001209191-19-040458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919119040458/doc4.xml","form_type":"4"}}]}